Article
Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult Population
2024-12-18
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction</bold> Metabolic dysfunction associated steatotic liver disease (MASLD) has replaced NAFLD as the diagnostic standard. This study aimed to validate steatosis and fibrosis non-invasive tests (NITs) used for NAFLD in predicting MASLD and advanced fibrosis, compared to transient elastography (TE), respectively. <bold>Methods</bold> This cross-sectional study used the NHA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 68da136b-2f87-5ebd-ac64-bc911c41bf3b
- DOI
- 10.21203/rs.3.rs-5456895/v1
